Second complete remission of relapsed medulloblastoma induced by metronomic chemotherapy.

Warning

This publication doesn't include Faculty of Economics and Administration. It includes Faculty of Medicine. Official publication website can be found on muni.cz.
Authors

ŠTĚRBA Jaroslav PAVELKA Zdeněk ANDRÉ Nicolas VENTRUBA Jiří SKOTÁKOVÁ Jarmila BAJČIOVÁ Viera BRONIŠOVÁ Danica DUBSKÁ Lenka VALÍK Dalibor

Year of publication 2010
Type Article in Periodical
Magazine / Source Pediatric Blood Cancer
MU Faculty or unit

Faculty of Medicine

Citation
Doi http://dx.doi.org/10.1002/pbc.22382
Field Oncology and hematology
Keywords metronomic chemotherapy; relapsed medulloblastoma
Description Prognosis for children with relapsed medulloblastoma remains poor. Metronomic chemotherapy may offer some benefit to patients treated initially with intensive regimens. However, dosing and duration of such palliative treatment have not been systematically studied. Here we describe a child with medulloblastoma relapsing after initial high-dose chemotherapy and standard radiotherapy. The patient was then treated with metronomic chemotherapy and achieved second complete remission after 21 months of treatment. Three months off therapy he relapsed again and died from progressive disease. This case illustrates the potential benefit of metronomic chemotherapy but also shows the uncertainty of when to stop metronomic chemotherapy while balancing toxicity.
Related projects:

You are running an old browser version. We recommend updating your browser to its latest version.